Abstract:Alcoholism is a complex disorder that, in man, appears to be genetically influenced, although the underlying genes and molecular pathways are not completely known. Here, the intragastric alcohol feeding model in rodents was used together with high mass accuracy LC-MS(n) analysis to assess the metabonomic changes in nonpolar metabolite profiles for livers from control and alcohol-treated rats and mice. Ion signals with a peak area variance of less than 30% (based on repeat analysis of a pooled quality control sample analyzed throughout the batch) were submitted to multivariate statistical analysis (using principal components analysis, PCA). PCA revealed robust differences between profiles from control and alcohol-treated animals from both species. The major metabolites seen to differ between control and alcohol-treated animals were identified using high accuracy MS(n) data and verified using external search engines ( http://www.lipidmaps.org ; http://www.hmdb.ca; http://www.genome.jp/kegg/ ) and authentic standards. The main metabolite classes to show major changes in the alcoholic liver-derived samples were fatty acyls, fatty acid ethyl esters, glycerolipids, and phosphatidylethanol homologues. Significant metabolites that were up-regulated by alcohol treatment in both rat and mouse livers included fatty acyls, metabolites such as octadecatrienoic acid and eicosapentaenoic acid, a number of fatty acid ethyl esters such as ethyl arachidonate, ethyl docosahexaenoic acid, ethyl linoleate, and ethyl oleate and phosphatidylethanol (PEth) homologues (predominantly PEth 18:0/18:2 and PEth 16:0/18:2; PEth homologues are currently considered as potential biomarkers for harmful and prolonged alcohol consumption in man). A number of glycerophospholipids resulted in both up-regulation (m/z 903.7436 [M + H](+) corresponding to a triglyceride) and down-regulation (m/z 667.5296 [M + H](+) corresponding to a diglyceride). Metabolite profiles were broadly similar in both mouse and rat models. However, there were a number of significant differences in the alcohol-treated group particularly in the marked down-regulation of retinol and free cholesterol in the mouse compared to the rat. Unique markers for alcohol treatment included ethyl docosahexaenoic acid. Metabolites were identified with high confidence using predominantly negative ion MS(n) data for the fatty acyl components to match to www.lipidmaps.org MS and MS/MS databases; interpreting positive ion data needed to take into account possible adduct ions which may confound the identification of other lipid classes. The observed changes in lipid profiles were consistent with alcohol-induced liver injury in humans.

Subcellular Proteome Analysis of Immune or Alcohol Induced Rat Liver Fibrosis

A dynamic plasma membrane proteome analysis of alcohol-induced liver cirrhosis

Subcellular Proteome Analysis Unraveled Annexin A2 Related to Immune Liver Fibrosis

Proteome Analysis of Hepatic Non-Parenchymal Cells of Immune Liver Fibrosis Rats

Proteome analysis of liver nonparenchymal cells from rats with alcoholic liver fibrosis

Dynamic Changes of Key Metabolites During Liver Fibrosis in Rats.

Plasma membrane proteome analysis of the early effect of alcohol on liver: implications for alcoholic liver disease.

Expression of vascular endothelial growth factor in chronic alcoholic liver fibrosis in rats

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Pattern of Microrna Expression Associated with Different Stages of Alcoholic Liver Disease in Rat Models

Expression Pattern of Matrix Metalloproteinases-13 in a Rat Model of Alcoholic Liver Fibrosis.

Proteomic Signature of Acute Liver Failure: from Discovery and Verification in a Pig Model to Confirmation in Humans.

Identification of Effective Diagnostic Biomarker and Immune Cell Infiltration Characteristics in Acute Liver Failure by Integrating Bioinformatics Analysis and Machine-Learning Strategies

A serum metabonomic study on the difference between alcohol- and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry.

Molecular Classification Of Liver Cirrhosis In A Rat Model By Proteomics And Bioinformatics

Functional Proteomic Analysis of Nonalcoholic Fatty Liver Disease in Rat Models: Enoyl-coenzyme a Hydratase Down-Regulation Exacerbates Hepatic Steatosis

Differential Proteomic Analysis of Dimethylnitrosamine (DMN)-Induced Liver Fibrosis.

Label‑free Quantitative Proteomics and Bioinformatics Analyses of Alcoholic Liver Disease in a Chronic and Binge Mouse Model

Metabonomic investigation of liver profiles of nonpolar metabolites obtained from alcohol-dosed rats and mice using high mass accuracy MSn analysis.

Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis

Novel potential biomarkers for severe alcoholic liver disease